Company news
Abingdon Health PLC news in 2021
Abingdon Health PLC's news releases, calls and decks from 2021, newest first.
Results of General Meeting and Open Offer
December 20, 2021
CE-marking and commercial launch of Semi-Q Test
December 16, 2021
Publication of Annual Report and Notice of AGM
December 3, 2021
Open Offer Launch, Posting of Circular, GM Notice
December 2, 2021
Result of Placing, PrimaryBid and Subscription
December 1, 2021
Close of Accelerated Bookbuild & PrimaryBid Offer
December 1, 2021
PrimaryBid Offer
December 1, 2021
Proposed Fundraising
December 1, 2021
Launch of Semi-Quantitative Accessory to AbC-19T
September 7, 2021
Launch of BioSURE COVID-19 IgG Antibody Self Test
August 23, 2021
Disclosure of Detailed Grounds for Resistance
August 9, 2021
Publication of an article regarding AbC-19
July 27, 2021
Exclusive Manufacturing Agreement with BioSure
July 23, 2021
Peer reviewed study involving AbC 19
July 9, 2021
Manufacturing Agreement with Bioporto A/S
July 5, 2021
Grant of Options under SAYE Scheme
April 23, 2021
Abingdon Health Notes Announcement by UK-RTC on...
April 19, 2021
Director Dealing
April 6, 2021
AbC-19™ Rapid Test used in UK BioBank COV...
March 29, 2021
Webinar: The role of antibody testing as a comp...
March 10, 2021
Data on AbC-19 as CDx for Pfizer-BioNTech Vaccine
February 24, 2021
Notice of Interim Results
February 23, 2021
Abingdon Health Notes Announcement by UK-RTC
February 16, 2021
Collaboration with Abcam
February 9, 2021
Statement re Media Article
February 8, 2021
Media Clarification
January 27, 2021
Appointment of Chief Financial Officer
January 26, 2021